Literature DB >> 33330813

Identifying medical professionals at risk for in-hospital COVID-19 infection: a snapshot during a "tsunami" highlighting unexpected risks.

Guido Torzilli1,2, Simone Famularo1, Elena Azzolini3, Edoardo Vespa4, Ana Lleo2,4, Alessio Aghemo2,4, Michele Lagioia3, Carlo Castoro2,5.   

Abstract

The aim of this study was to profile healthcare professionals (HCPs) who infected with COVID-19 in hospital while working in a COVID-19 hub hospital during the pandemic. A questionnaire was sent to all HCPs from whom nasopharyngeal swabs (NPS) were collected. The type of work, work environment, individual characteristics, and modality of infection were analyzed. Working areas were categorized into COVID-free areas (wards and ICUs for patients without COVID-19, medical offices, and hospitality counters) and COVID+ areas (dedicated wards and the ICU for patients with COVID-19). From March 1 to 20, 2020, 302 HCPs were tested: 251 (83.1%) responded to the questionnaire, but 9 were excluded since infection occurred outside the hospital. The remaining 242 subjects included 53 (21.9%) with positive NPS and 189 (78.1%) with negative NPS, significant differences in NPS results were evident depending on the subject's role (p = 0.028). Pairwise post hoc analysis revealed that surgeons had a significantly increased rate of positive NPS (p = 0.001). Of the 189 subjects with negative NPS, 175 (92.6%) worked in COVID-free areas, and 14 (7.4%) in COVID+ areas. Of the 53 subjects with positive NPS, 44 (83.1%) worked in COVID-free areas and 9 (16.9%) worked in COVID+ areas. Medical offices featuring an open space with adjacent desks were identified as areas of higher risk. An apparent cause of infection could not be identified in 21 (39.6%) subjects with positive NPS. Among a total of 251 subjects, 80 (41.5%) of the 193 subjects with negative NPS and 16 (27.6%) of the 58 subjects with positive NPS had been vaccinated against the common flu. In conclusion, the vast majority of subjects with positive NPS came from COVID-free areas. The source of infection could not be identified in a significant portion of subjects with positive NPS. Personnel need better protection, more testing with NPS needs to be performed, and workplace layouts need to be re-thought. Vaccination against the flu seems to provide some protection. 2020, National Center for Global Health and Medicine.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; healthcare personnel; healthcare system

Year:  2020        PMID: 33330813      PMCID: PMC7731090          DOI: 10.35772/ghm.2020.01052

Source DB:  PubMed          Journal:  Glob Health Med        ISSN: 2434-9186


  4 in total

1.  Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.

Authors:  Kelvin Kai-Wang To; Owen Tak-Yin Tsang; Wai-Shing Leung; Anthony Raymond Tam; Tak-Chiu Wu; David Christopher Lung; Cyril Chik-Yan Yip; Jian-Piao Cai; Jacky Man-Chun Chan; Thomas Shiu-Hong Chik; Daphne Pui-Ling Lau; Chris Yau-Chung Choi; Lin-Lei Chen; Wan-Mui Chan; Kwok-Hung Chan; Jonathan Daniel Ip; Anthony Chin-Ki Ng; Rosana Wing-Shan Poon; Cui-Ting Luo; Vincent Chi-Chung Cheng; Jasper Fuk-Woo Chan; Ivan Fan-Ngai Hung; Zhiwei Chen; Honglin Chen; Kwok-Yung Yuen
Journal:  Lancet Infect Dis       Date:  2020-03-23       Impact factor: 25.071

2.  A Snapshot of Elective Oncological Surgery in Italy During COVID-19 Emergency: Pearls, Pitfalls, and Perspectives.

Authors:  Guido Torzilli; Luca Viganò; Jacopo Galvanin; Carlo Castoro; Vittorio Quagliuolo; Antonino Spinelli; Alessandro Zerbi; Matteo Donadon; Marco Montorsi
Journal:  Ann Surg       Date:  2020-08       Impact factor: 12.969

Review 3.  Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control.

Authors:  Cheryl Yi-Pin Lee; Raymond T P Lin; Laurent Renia; Lisa F P Ng
Journal:  Front Immunol       Date:  2020-04-24       Impact factor: 7.561

4.  Protecting healthcare workers from SARS-CoV-2 infection: practical indications.

Authors:  Martina Ferioli; Cecilia Cisternino; Valentina Leo; Lara Pisani; Paolo Palange; Stefano Nava
Journal:  Eur Respir Rev       Date:  2020-04-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.